3D Signatures (TSX-V:DXD) has appointed Nigel Terrett to 3DS’s business advisory board to provide the company with strategic insight and guidance related to commercial lab partnerships and information technology management for its diagnostic platform.
Mr. Terrett brings extensive commercial lab experience to 3DS, which includes executive roles with several major commercial labs and electronic health record companies, such as Excelleris Technologies, Lifelabs and MDS Diagnostics.
In a statement, John Swift, chairman of 3DS, said Mr. Terrett’s guidance in the development and commercialization of the company’s entirely new class of minimally invasive biomarkers will be invaluable, given his extensive history of success in the medical diagnostics industry.
“Mr. Terrett will help us navigate the complex commercial laboratory marketplace, such that we ensure physicians and patients have access to 3D Signatures’ product pipeline, that we believe to be at the forefront of specialized clinical tests in the cancer and Alzheimer’s space,” he added.
